Live Chat
During This Challenging Time

We are open for business and remain dedicated to your case! All those working on-site and remotely are still available to answer your questions. The well-being of our clients and staff are vital, so we will provide updates as the situation progresses.

During This Challenging Time Close

Fears Nachawati Investigating Possible Uloric Lawsuits After FDA Issues Strongest Warning for Gout Drug

March 11, 2019

National law firm Fears Nachawati is launching an immediate investigation into the popular gout drug Uloric, manufactured by Takeda Pharmaceuticals, after the U.S. Food and Drug Administration (FDA) issued a boxed warning stemming from of the increased risk of death from Uloric use.

The law firm is encouraging anyone who has experienced serious health problems or whose family members died after Uloric use to consult an attorney as soon as possible. They may be justified in pursuing a lawsuit against the drug’s maker.

On Feb. 21, 2019, the FDA concluded that there is an increased risk of death from Uloric (febuxostat) compared to another gout medicine, Zyloprim (allopurinol.) This conclusion is based on the FDA’s in-depth review of results from a clinical safety study, which found a higher risk of heart-related deaths when taking Uloric.

The FDA ordered a boxed warning be put on Uloric, as well as a new patient medication guide. The FDA is also limiting the approved use of Uloric to certain patients who either have an adverse reaction to allopurinol or where that drug has not been an effective treatment.

“It’s hard to believe that a medication meant to help could actually end lives,” said firm co-founder, Majed Nachawati. “While it can be difficult to think about legal action after the passing of a loved one, a lawsuit can help send a message that this is not OK.”

The FDA approved Uloric in 2009 for the chronic management of hyperuricemia, which occurs when there is too much uric acid in the bloodstream. High uric acid levels can lead to several diseases, including gout, a painful type of arthritis.

In March 2018, it was announced that Uloric was inexplicably linked to more cardiac deaths than was allopurinol, the usual drug given to patients with gout and cardiovascular disease. Before that announcement, the FDA requested that Uloric be removed from the market in a drug recall in November 2017.

Fears Nachawati law firm is now investigating possible Uloric lawsuits. The firm has a history of working with patients who have suffered from the effects of dangerous drugs and medical devices, such as hernia mesh, Invokana, IVC filters, opioids and Taxotere. The firm has built a significant reputation among the plaintiffs’ bar for seeing cases through to the end of litigation and fighting for clients’ rights.

If someone you know has passed away after using the gout medication Uloric, contact Fears Nachawati at 866-705-7584 to discuss a potential Uloric lawsuit.


Use the form below to send us a note, call us at 214.890.0711 or chat with us live. We are eager to help with your legal needs. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears Nachawati.

Contact Us


With offices across Texas, and attorneys licensed in Texas, Florida, Arkansas, New Mexico, California, Illinois, District of Columbia, Missouri and Oklahoma, Fears Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We strive to be professionals who are creative, empathetic and reliable.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consultation

Live Chat (Online Now)